Antinociceptive and anti-exudative synergism between dexketoprofen and tramadol in a model of inflammatory pain in mice
Author
dc.contributor.author
Miranda, Hugo F.
Author
dc.contributor.author
Romero, Maria Asunción
Author
dc.contributor.author
Puig, Margarita M.
Admission date
dc.date.accessioned
2019-03-11T13:03:49Z
Available date
dc.date.available
2019-03-11T13:03:49Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Fundamental and Clinical Pharmacology, Volumen 26, Issue 3, 2018, Pages 373-382
Identifier
dc.identifier.issn
07673981
Identifier
dc.identifier.issn
14728206
Identifier
dc.identifier.other
10.1111/j.1472-8206.2010.00922.x
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165523
Abstract
dc.description.abstract
Preclinical studies have demonstrated antinociceptive synergism between dexketoprofen (DEX) and tramadol (TRM) in acute animal models of nociception. The aim of the present study was to investigate the type of interaction between DEX and TRM in a chronic musculoskeletal pain model in mice, which fairly replicates the characteristics of chronic osteoarticular pain in humans. Inflammation was induced by a subplantar injection of complete Freund's adjuvant (CFA) in male CF1 mice. Nociceptive thresholds were evaluated using the hot plate, the nocifensive spontaneous behavior and the acetone tests, while plasma extravasation (PE) was assessed with Evan's blue. We used the following experimental groups: control (no inflammation), acute (1day after CFA injection), and chronic inflammation (7days after CFA). Dose-response curves for DEX and TRM, individually and combined in a 1:1 proportion based on their potency were obtained, and the doses that produced a 50% inhibition calculated. The isobo